[go: up one dir, main page]

KR890014470A - 카르바펜엠 중간체의 제조방법 - Google Patents

카르바펜엠 중간체의 제조방법 Download PDF

Info

Publication number
KR890014470A
KR890014470A KR1019890003685A KR890003685A KR890014470A KR 890014470 A KR890014470 A KR 890014470A KR 1019890003685 A KR1019890003685 A KR 1019890003685A KR 890003685 A KR890003685 A KR 890003685A KR 890014470 A KR890014470 A KR 890014470A
Authority
KR
South Korea
Prior art keywords
alkyl
enyl
azetidin
carboxyprop
producing
Prior art date
Application number
KR1019890003685A
Other languages
English (en)
Other versions
KR0125932B1 (ko
Inventor
쇼이찌로 우에오
Original Assignee
요시또시 가즈오
시오노기세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시또시 가즈오, 시오노기세이야꾸 가부시끼가이샤 filed Critical 요시또시 가즈오
Publication of KR890014470A publication Critical patent/KR890014470A/ko
Application granted granted Critical
Publication of KR0125932B1 publication Critical patent/KR0125932B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Automobile Manufacture Line, Endless Track Vehicle, Trailer (AREA)

Abstract

내용 없음.

Description

카르바펜엠 중간체의 제조방법
내용없음

Claims (25)

  1. 4-(이탈기 치환된) 아제티딘-2-온(Ⅰ)을 식(Ⅲ)의 트랜스-2-(이탈기 치환된)메틸-3-알킬아크릴산과 환원성 금속으로 반응시킴을 특징으로 하는 4β(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-은(Ⅱ)의 제조방법.
    (상기식에서, R1은 수소 또는 임의로 치환된 알킬 ; R2는 임의로 치환된 알킬 ; R3은 수소 또는 카르복시보호기 ; 그리고 R4와 R5는 각각 이탈기이다.)
  2. 제1항에 있어서, R1이 1C 내지 10C 알킬 3C 내지 18C 히드로카르빌실릴로 임의로 보호된 1C 내지 10C 히드록시알킬, 1C 내지 8C 할로알킬, 또는 4C 내지 8C 디옥소렌일인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  3. 제1항에 있어서, R1이 수소, 1C 내지 8C 알킬, 또는 1C 내지 8C 1-(임의로 보호된 히드록시 또는 할로) 알킬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘 -2-온(Ⅱ)의 제조방법.
  4. 제3항에 있어서, 임의의 보호기가 1C 내지 10C카르복실계 아실, 2C 내지 10C카르본계 아실, 2C 내지 8C 에테르 형성기, 3C 내지 18C 트리히드로카르빌실릴, 7C 내지 19C 반응성 아르알킬 인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온-(Ⅲ)의 제조방법.
  5. 제1항에 있어서, R1이 1-히드록시에틸, 1-(3차-부틸디메틸실옥시)에틸, 또는 1-(트리에틸실릴-옥시)에틸인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  6. 제1항에 있어서, R2가 1C 내지 8C알킬 또는 치환된 알킬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  7. 제1항에 있어서, R2가 1C 내지 3C알킬 또는 1C 내지 5C 할로겐알킬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  8. 제1항에 있어서, R2가 메틸 또는 에틸 인 4β-81β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  9. 제1항에 있어서, R3가 수소 또는 1C 내지 8C알킬인 4β-(1β-알킬-2-카르복시프로프 -2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  10. 제1항에 있어서, R3가 수소, 메틸 또는 에틸인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  11. 제1항에 있어서, R4와 R5가 각각 불소, 염소, 브롬, 또는 임의로 치환된 1C 내지 8C 알칸오일옥시, 7C 내지 15C 아로일옥시, 1C 내지 8C 알킬술폰일옥시, 1C 내지 8C 치환된 알킬술폰일옥시, 6C 내지 10C 아릴술폰일옥시, 1C 내지 8C 알킬술핀일, 또는 6C 내지 10C 아릴술핀일 인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  12. 제11항에 있어서, R4가 아세톡시이고 R5가 브롬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  13. 제1항에 있어서, 반응을 용매중에서 수행하는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  14. 제13항에 있어서, 용매가 테트라히드로푸란인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  15. 제1항에 있어서, 환원성 금속이 -0.1 내지 -0.8 볼트의 산화-환원 전위를 갖는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  16. 제1항에 있어서, 환원성 금속이 아연인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  17. 제16항에 있어서, 아연을 브롬화제 2구리로 활성 화한 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  18. 제1항에 있어서, 반응을 -10 내지 50℃에서 0.5 내지 10시간동안 수행하는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  19. 제18항에 있어서, 반응을 30 내지 35℃에서 3.5시간동안 수행하는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
  20. 하기식(Ⅱ)의 4β-(1β-알킬-2-카르복시-프로프-2-엔일)아제티딘-2-온(Ⅱ).
    (상기식에서, R1은 수소 또는 임의로 치환된 알킬 : R2는 임의로 치환된 알킬 : 그리고 R3는 수소 또는 카르복시보호기이다.)
  21. 제20항에 있어서, R1이 1-히드록시에틸, 1-(3차-부틸디메틸실릴옥시)에틸, 또는 1-(트리에틸실릴옥시)에틸 ; R2가 메틸 또는 에틸 ; 그리고 R3가 수소, 메틸, 또는 에틸인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)화합물.
  22. 제1항에 있어서의 방법의 조합 및 전술한 방법과 실질적으로 동종의 반응으로 이루어진 항균물질 1-카르바펜-2-엠 화합물의 제조방법.
  23. 실질적으로 전술한 반응을 거쳐 제조된 항균물질 1-카르바펜-2-엠 화합물.
  24. 제23항에 있어서, 전술한 실시예에 기술된 것과 실질적으로 동일한 반응에 의해 제조된 항균물질 1-카르바펜-2-엠 화합물.
  25. 활성 성분으로서, 제23항에 청구된 1-카르바펜-2-엠을 함유하는 항균성 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890003685A 1988-03-23 1989-03-23 카르바펜엠 중간체의 제조방법 KR0125932B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP63-70763 1988-03-23
JP070763/1988 1988-03-23
JP7076388 1988-03-23

Publications (2)

Publication Number Publication Date
KR890014470A true KR890014470A (ko) 1989-10-23
KR0125932B1 KR0125932B1 (ko) 1997-12-26

Family

ID=13440875

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890003685A KR0125932B1 (ko) 1988-03-23 1989-03-23 카르바펜엠 중간체의 제조방법

Country Status (9)

Country Link
US (1) US4960879A (ko)
EP (1) EP0336143B1 (ko)
KR (1) KR0125932B1 (ko)
AT (1) ATE90343T1 (ko)
AU (1) AU613724B2 (ko)
CA (1) CA1340115C (ko)
DE (1) DE68906945T2 (ko)
ES (1) ES2017596T3 (ko)
GB (1) GB2216525B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054604T3 (es) * 1987-09-22 1995-12-01 Shionogi & Co Intermedios alquenilsililazetidinona para carbapenemes.
CA2000565C (en) * 1988-10-19 1998-06-23 Masaji Ishiguro Process for the preparation of 4-acyloxy-2-azetidinone derivatives
US4992545A (en) * 1989-09-20 1991-02-12 Eli Lilly And Company Process for preparing 4-substituted azetidinones
JPH03120280A (ja) * 1989-10-03 1991-05-22 Shionogi & Co Ltd ハロメチルカルバペネム化合物の製法
FI96311C (fi) * 1989-12-04 1996-06-10 Squibb Bristol Myers Co Menetelmä farmaseuttisesti käyttökelpoisten 6-(1-hydroksietyyli)-3-(substituoitu tio)-7-okso-1-atsabisyklo/3.2.0/hept-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi
US5672701A (en) * 1990-01-16 1997-09-30 Bristol-Myers Squibb Company 4-substituted alkyl carbapenem antibiotics
US5068232A (en) * 1990-04-10 1991-11-26 American Cyanamid Company Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US6216687B1 (en) 1996-03-22 2001-04-17 The Majestic Products Company Unvented heating appliance having system for reducing undesirable combustion products
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
CA2276365A1 (en) * 1997-01-21 1998-07-23 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US6346617B1 (en) 1997-08-26 2002-02-12 Merck & Co., Inc. Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof
US6143885A (en) * 1997-08-27 2000-11-07 Merck & Co., Inc. Preparation of beta-methyl carbapenem intermediates
CA2298977A1 (en) * 1997-08-27 1999-03-04 Merck & Co., Inc. Preparation of beta-methyl carbapenem intermediates
WO2005123069A2 (en) * 2004-06-10 2005-12-29 Fob Synthesis, Inc. Gram-positive carbapenem antibacterials and processes for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE10838T1 (de) * 1980-02-28 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
JPS60158167A (ja) 1984-01-27 1985-08-19 Sumitomo Chem Co Ltd β−ラクタム化合物の製造法
EP0180189B1 (en) * 1984-10-31 1991-01-23 Sumitomo Pharmaceuticals Company, Limited Novel beta-lactams and their production
DE3509769A1 (de) * 1985-03-19 1986-09-25 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von carbapenemzwischenprodukten
JPS6229577A (ja) 1985-07-31 1987-02-07 Sumitomo Pharmaceut Co Ltd オキサゾリジン誘導体
JPS62103063A (ja) * 1985-10-29 1987-05-13 Sagami Chem Res Center アゼチジノン誘導体の製造方法

Also Published As

Publication number Publication date
US4960879A (en) 1990-10-02
EP0336143A1 (en) 1989-10-11
DE68906945T2 (de) 1993-10-14
KR0125932B1 (ko) 1997-12-26
ES2017596A4 (es) 1991-03-01
GB2216525A (en) 1989-10-11
GB8906597D0 (en) 1989-05-04
CA1340115C (en) 1998-11-03
ATE90343T1 (de) 1993-06-15
DE68906945D1 (de) 1993-07-15
AU613724B2 (en) 1991-08-08
AU3159989A (en) 1989-09-28
GB2216525B (en) 1992-01-02
ES2017596T3 (es) 1994-10-16
EP0336143B1 (en) 1993-06-09

Similar Documents

Publication Publication Date Title
KR890014470A (ko) 카르바펜엠 중간체의 제조방법
KR840005448A (ko) 티에노〔3, 2-c〕 피리딘 유도체의 제조방법
AU600897B2 (en) N-acyl-alpha-amino-alpha-hydroxy acetic acid ester
KR840004066A (ko) 옥심 에테르의 제조방법
JPS5745200A (en) Anti-inflammatory steroid and pharmacological composition containing the same
ES531296A0 (es) Un derivado de acido tiazolilacetico
JPS5549352A (en) Cyclic iminocarboxylic acid derivative and its salt
HU193460B (en) Process for production of peneme derivatives
JPS5576873A (en) Coumarin derivative, its preparation, and antiallergic drugs containing it as active constituent
GB1506302A (en) 1-alkyl-2-(phenoxymethyl)-5-nitro-imidazoles and processes for their preparation
JPS55147284A (en) Novel beta-lactam derivative and its preparation
JPS5466695A (en) Azetidinone derivative and its preparation
JPS5610165A (en) Novel beta-lactam compound and its production
JPS5798257A (en) 3,4-disubstituted azetidine-2-one compound and its preparation
JPS57175176A (en) Morpholine derivatives, manufacture and composition
JPS5753480A (en) Tetrahydro-1-alkylthiophenium derivative
JPS54128567A (en) 1-substituted-4-acyl-2-pyrrolecarboxylic acid derivative
JPS5359664A (en) Novel imidazole derivatives
JPS5653654A (en) Preparation of novel aniline derivative
JPS6422866A (en) Tetrahydrofuran derivative
JPS55108898A (en) 25-hydroxy-24-oxocholesterol derivative and its preparation
JPS55154957A (en) 77methyl and 77methyll88lower alkyl b*c cis or transsmorphinann66one compound
KR850001744A (ko) 4-r'-5-q-1,6-나프티리딘-2(1h)-온류의 제법
JPS5711975A (en) Aminophenyltetrazole derivative and salt thereof
JPS56145271A (en) 2-azetidinone derivative

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890323

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19931112

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19890323

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19970428

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19970718

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19971010

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19971010

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20000809

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20010808

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20020808

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20030814

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20041004

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20050926

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20060925

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20070920

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20080925

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20090925

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20101007

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20110920

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20110920

Start annual number: 15

End annual number: 15

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20130709

Termination category: Expiration of duration